BRUSSELS — Solvay is partnering with Gingko Bioworks, a cell programming platform, to develop sustainable biopolymers for food, agriculture and personal care applications. As part of the agreement, Solvay also will acquire a Gingko laboratory in Cambridge, Mass., to expand its research and innovation capabilities.

“We’re thrilled to make this important investment and to partner with Ginkgo Bioworks on an exciting project to develop sustainable chemicals and materials, allowing us to provide innovative biotechnologies to new markets,” said Illham Kadri, chief executive officer of Solvay. “Biotech is the future and this step is an important milestone for our growth platform. We expect to leverage our new presence in the Boston area to step up and accelerate our offerings in this field.”

The partnership is part of Solvay’s growth strategy for its renewable carbon and biotechnology platform.